<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03125941</url>
  </required_header>
  <id_info>
    <org_study_id>DEXMAS01</org_study_id>
    <secondary_id>2017-000227-27</secondary_id>
    <nct_id>NCT03125941</nct_id>
  </id_info>
  <brief_title>High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy</brief_title>
  <acronym>DEX-MAS</acronym>
  <official_title>Effect of High vs Low Dose Intravenous Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy- a Randomized, Double-blind, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effect of a single preoperative high-dose steroid
      injection on complications in the immediate postoperative phase after breast cancer surgery,
      with removal of the breast (mastectomy). Primary outcome is the proportion patients who
      require transfer to the post anaesthesia care unit (PACU) and the proportion that can be
      transferred directly to the ward. Secondary outcomes are organospecific complications in the
      postanesthesia phase, pain and nausea the first 5 days, seroma and wound infection the first
      14 days and readmissions the first 30 days after surgery.

      The investigators hypothesize that the frequency of transfer to the PACU and organospecific
      complications will be lower among patients receiving high dose dexamethasone. The
      investigators hypothesize, that there will be no difference in wound infections, seroma or
      readmissions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-surgery, patients are traditionally observed and treated in post-anesthesia care units
      (PACU) until they are discharged to the ward (or directly home) assessed by standardized
      international discharge criteria.

      The research project &quot;Why in PACU?&quot; (Rigshospitalet, Denmark), has since the beginning of
      2016 systematically collected and analyzed procedure-related complications in the recovery
      phase. The complications include pain, nausea/vomiting, circulatory and respiratory problems,
      orthostatic intolerance and cognitive disorders. Common to all the above-mentioned
      post-operative problems are the possible links to the inflammatory response caused by the
      surgical trauma.

      Glucocorticoids can in this context be central for the reduction of acute postoperative organ
      dysfunctions, caused by the anti-inflammatory effect. In a number of different surgical
      procedures, single dose, pre-operative glucocorticoids have been shown to reduce
      post-operative nausea and vomiting (PONV), acute pain and need of opioids as well as
      accelerate the convalescence.

      Meta-analyses also showed that single-dose administration of glucocorticoids
      (methylprednisolone and dexamethasone) for surgical patients is safe as opposed to long-term
      treatment.

      Based on positive results in other procedure-specific studies, all mastectomy patients at
      Rigshospitalet, have received pre-operative high-dose steroids, in the form of 24 mg
      dexamethasone injection since mid-2015. This has resulted in a decrease in the proportion of
      patients who need observation in PACU from 30 % to 10 %. The reduction is primarily due to
      less pain, less sedation, and lower opioid administration.

      Whether this is also partly due to a &quot;systemic effect&quot; (Hawthorn effect) as a result of
      increased focus on the area cannot be excluded.

      Prior to creating clinical recommendations and standards, it is required that the results be
      tested in a randomized, controlled, clinical trial.

      The study is not placebo-controlled since the positive effects of dexamethasone 8 mg on PONV
      have been shown in numerous trials, and is already being administered to all patients at the
      clinic. It would therefore not be ethically correct to withdraw from this practise.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 27, 2017</start_date>
  <completion_date type="Actual">April 22, 2018</completion_date>
  <primary_completion_date type="Actual">April 22, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Transfer to Post-anesthesia Care Unit (PACU)</measure>
    <time_frame>Within 1 hour post-surgery</time_frame>
    <description>Number of patients meeting criteria for transfer to PACU post-surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Discharge Score,(Modified Aldrete Discharge Score), Operating Room</measure>
    <time_frame>At transfer from operating room, within 1 hour post-surgery</time_frame>
    <description>Danish Society of Anesthesiology and Intensive Care Medicine (DASAIM) discharge score.Construct: The score consists of six modalities (subscores): Sedation,Oxygen saturation,blood pressure,heart rate,pain (at rest)and nausea.Each modality has a score between 0 and 3,and patients are considered dischargeable to the ward when the score sum of all criteria (total score) is 4 or less and no single score is above 1. All values (subscores) are considered best at 0 and worst at 3.
Sedation: 0 fully awake, 1, sleeping aroused by verbal stimuli, 2 sleeping aroused by physical stimuli, 3 sleeping cannot be aroused.
Oxygen saturation (%):0 ≥94, 1 90-93, 2 85-89, 3 &lt;85. Blood pressure, systolic (mmHg): 0 100-220, 1 90-99. 2 80-89 or &gt;220, 3&lt;80. Heart rate; pr. min: 0 50-100, 1 101-120, 2 40-49 or 121-130, 3 &lt;40 or &gt;130. Pain (at rest) (Numeric rating scale 0-10): 0 0, 1 0-2, 2 3-6, 3 ≥ 7 Nausea (patient evaluation and nurse observation): 0 none, 1 light, 2 moderate, 3 severe or vomiting.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge Score, Arrival at PACU</measure>
    <time_frame>within 3 hours</time_frame>
    <description>DASAIM score (Danish Society of Anesthesiology and Intensive Care Medicine). The score consists of six modalities: Sedation, Oxygen saturation, blood pressure, heart rate, pain (at rest) and nausea.
Each modality has a score between 0 and 3, and patients are considered dischargeable to the ward when the score sum of all criteria is four or less and no single score is above one.
Sedation: 0 fully awake, 1, sleeping aroused by verbal stimuli, 2 sleeping, aroused by physical stimuli, 3 sleeping, cannot be aroused.
Oxygen saturation (%): 0 ≥ 94, 1 90-93, 2 85-89, 3 &lt;85. Blood pressure, systolic (mmHg): 0 100-220, 1 90-99. 2 80-89 or &gt;220, 3&lt;80. Heart rate; pr. min: 0 50-100, 1 101-120, 2 40-49 or 121-130, 3 &lt;40 or &gt;130. Pain (at rest) (Numeric rating scale 0-10): 0 0, 1 0-2, 2 3-6, 3 ≥ 7 Nausea (patient evaluation and nurse observation): 0 none, 1 light, 2 moderate, 3 severe or vomiting.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discharge Score, Arrival at Ward</measure>
    <time_frame>within 3 hours</time_frame>
    <description>DASAIM score (Danish Society of Anesthesiology and Intensive Care Medicine). The score consists of six modalities: Sedation, Oxygen saturation, blood pressure, heart rate, pain (at rest) and nausea.
Each modality has a score between 0 and 3, and patients are considered dischargeable to the ward when the score sum of all criteria is four or less and no single score is above one.
Sedation: 0 fully awake, 1, sleeping aroused by verbal stimuli, 2 sleeping, aroused by physical stimuli, 3 sleeping, cannot be aroused.
Oxygen saturation (%): 0 ≥ 94, 1 90-93, 2 85-89, 3 &lt;85. Blood pressure, systolic (mmHg): 0 100-220, 1 90-99. 2 80-89 or &gt;220, 3&lt;80. Heart rate; pr. min: 0 50-100, 1 101-120, 2 40-49 or 121-130, 3 &lt;40 or &gt;130. Pain (at rest) (Numeric rating scale 0-10): 0 0, 1 0-2, 2 3-6, 3 ≥ 7 Nausea (patient evaluation and nurse observation): 0 none, 1 light, 2 moderate, 3 severe or vomiting.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Complication</measure>
    <time_frame>24 hours</time_frame>
    <description>complications requiring treatment until discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Length of Stay in PACU</measure>
    <time_frame>12 hours</time_frame>
    <description>Length of stay in the post-anesthesia care unit (PACU), measured as hours and minutes, from start of procedure, to discharge from PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Length of Stay in Hospital</measure>
    <time_frame>24-48 hours</time_frame>
    <description>Length of stay in hospital, measured from start of procedure to discharge from hospital to home</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Transfer</measure>
    <time_frame>24-48 hours</time_frame>
    <description>Secondary transfer to PACU from ward, or to intensive care unit from PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain, Numeric Rating Scale</measure>
    <time_frame>days 0-4</time_frame>
    <description>Self-reported pain (worst and average (average through that day), days 0-4) on a numeric rating scale (NRS) 0-10. 0 is no pain, 10 is worst pain imaginable.. Questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post Operative Nausea and Vomiting (PONV).</measure>
    <time_frame>days 0-4</time_frame>
    <description>Self-reported nausea, questionnaire, day 0-4. Number of participants reporting nausea and/or vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Sleep</measure>
    <time_frame>days 0-4</time_frame>
    <description>Self-reported quality of sleep (days 0-4). Questionnaire. Dichotomized to Good sleep or sleep problems, numbers reported are number of patients with sleep problems</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mental Status</measure>
    <time_frame>days 0-4</time_frame>
    <description>Self-reported feelings of restlessness, sadness and fatigue (days 0-4). Questionnaire (anwers possible: yes or no. Numbers are patients answering yes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Seroma, Requiring Treatment</measure>
    <time_frame>14 days</time_frame>
    <description>Seroma, requiring treatment the first 14 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission</measure>
    <time_frame>30 days</time_frame>
    <description>Any readmission, days 0-30</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Dexamethasone</condition>
  <condition>Glucocorticoids</condition>
  <condition>Mastectomy</condition>
  <condition>Breast Cancer</condition>
  <condition>Pain, Postoperative</condition>
  <condition>Nausea and Vomiting, Postoperative</condition>
  <condition>Steroid</condition>
  <condition>Systemic Inflammatory Response Syndrome</condition>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Dexamethasone 8 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone 8 mg pre-operative</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone 24 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone 24 mg pre-operative</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>pre-operative intravenous administration</description>
    <arm_group_label>Dexamethasone 24 mg</arm_group_label>
    <arm_group_label>Dexamethasone 8 mg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  planned unilateral mastectomy with or without axillary dissection or sentinel node in
             the study period

          -  informed signed consent

        Exclusion Criteria:

          -  Chronic/ongoing use of glucocorticoids (except inhalation therapy)

          -  ongoing use of immunosuppressive therapy

          -  insulin dependent diabetes

          -  pregnancy/breastfeeding

          -  allergies toward study medication, or medication in a standard treatment

          -  contralateral surgery (lumpectomy/mastectomy) at time of mastectomy

          -  surgery cannot be performed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristin J Steinthorsdottir, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>March 28, 2017</study_first_submitted>
  <study_first_submitted_qc>April 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <results_first_submitted>May 2, 2019</results_first_submitted>
  <results_first_submitted_qc>November 27, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">December 2, 2019</results_first_posted>
  <last_update_submitted>November 27, 2019</last_update_submitted>
  <last_update_submitted_qc>November 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Kristin Julia Steinthorsdottir</investigator_full_name>
    <investigator_title>Principal investigator, MD, Clinical assistant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Not planned to share IPD</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 16, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT03125941/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Dexamethasone 8 mg</title>
          <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
        </group>
        <group group_id="P2">
          <title>Dexamethasone 24 mg</title>
          <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="65"/>
                <participants group_id="P2" count="65"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Post-randomization Exclusion</title>
              <participants_list>
                <participants group_id="P1" count="1">procedure changed, did not receive intervention</participants>
                <participants group_id="P2" count="2">procedure changed, did not receive intervention</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="64"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>did not receive intervention</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Dexamethasone 8 mg</title>
          <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
        </group>
        <group group_id="B2">
          <title>Dexamethasone 24 mg</title>
          <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="65"/>
            <count group_id="B2" value="65"/>
            <count group_id="B3" value="130"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="65"/>
                    <count group_id="B2" value="65"/>
                    <count group_id="B3" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66" lower_limit="28" upper_limit="87"/>
                    <measurement group_id="B2" value="63" lower_limit="24" upper_limit="85"/>
                    <measurement group_id="B3" value="65" lower_limit="24" upper_limit="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="65"/>
                    <count group_id="B2" value="65"/>
                    <count group_id="B3" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="128"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Transfer to Post-anesthesia Care Unit (PACU)</title>
        <description>Number of patients meeting criteria for transfer to PACU post-surgery</description>
        <time_frame>Within 1 hour post-surgery</time_frame>
        <population>primary outcome was per intention to treat, secondary outcomes were per protocol (we had 3 post-randomization exclusions, that did not receive the intervention)</population>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Transfer to Post-anesthesia Care Unit (PACU)</title>
          <description>Number of patients meeting criteria for transfer to PACU post-surgery</description>
          <population>primary outcome was per intention to treat, secondary outcomes were per protocol (we had 3 post-randomization exclusions, that did not receive the intervention)</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="65"/>
                <count group_id="O2" value="65"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1</p_value>
            <method>Chi-squared</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.49</ci_lower_limit>
            <ci_upper_limit>2.05</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Discharge Score,(Modified Aldrete Discharge Score), Operating Room</title>
        <description>Danish Society of Anesthesiology and Intensive Care Medicine (DASAIM) discharge score.Construct: The score consists of six modalities (subscores): Sedation,Oxygen saturation,blood pressure,heart rate,pain (at rest)and nausea.Each modality has a score between 0 and 3,and patients are considered dischargeable to the ward when the score sum of all criteria (total score) is 4 or less and no single score is above 1. All values (subscores) are considered best at 0 and worst at 3.
Sedation: 0 fully awake, 1, sleeping aroused by verbal stimuli, 2 sleeping aroused by physical stimuli, 3 sleeping cannot be aroused.
Oxygen saturation (%):0 ≥94, 1 90-93, 2 85-89, 3 &lt;85. Blood pressure, systolic (mmHg): 0 100-220, 1 90-99. 2 80-89 or &gt;220, 3&lt;80. Heart rate; pr. min: 0 50-100, 1 101-120, 2 40-49 or 121-130, 3 &lt;40 or &gt;130. Pain (at rest) (Numeric rating scale 0-10): 0 0, 1 0-2, 2 3-6, 3 ≥ 7 Nausea (patient evaluation and nurse observation): 0 none, 1 light, 2 moderate, 3 severe or vomiting.</description>
        <time_frame>At transfer from operating room, within 1 hour post-surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Discharge Score,(Modified Aldrete Discharge Score), Operating Room</title>
          <description>Danish Society of Anesthesiology and Intensive Care Medicine (DASAIM) discharge score.Construct: The score consists of six modalities (subscores): Sedation,Oxygen saturation,blood pressure,heart rate,pain (at rest)and nausea.Each modality has a score between 0 and 3,and patients are considered dischargeable to the ward when the score sum of all criteria (total score) is 4 or less and no single score is above 1. All values (subscores) are considered best at 0 and worst at 3.
Sedation: 0 fully awake, 1, sleeping aroused by verbal stimuli, 2 sleeping aroused by physical stimuli, 3 sleeping cannot be aroused.
Oxygen saturation (%):0 ≥94, 1 90-93, 2 85-89, 3 &lt;85. Blood pressure, systolic (mmHg): 0 100-220, 1 90-99. 2 80-89 or &gt;220, 3&lt;80. Heart rate; pr. min: 0 50-100, 1 101-120, 2 40-49 or 121-130, 3 &lt;40 or &gt;130. Pain (at rest) (Numeric rating scale 0-10): 0 0, 1 0-2, 2 3-6, 3 ≥ 7 Nausea (patient evaluation and nurse observation): 0 none, 1 light, 2 moderate, 3 severe or vomiting.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.114</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Discharge Score, Arrival at PACU</title>
        <description>DASAIM score (Danish Society of Anesthesiology and Intensive Care Medicine). The score consists of six modalities: Sedation, Oxygen saturation, blood pressure, heart rate, pain (at rest) and nausea.
Each modality has a score between 0 and 3, and patients are considered dischargeable to the ward when the score sum of all criteria is four or less and no single score is above one.
Sedation: 0 fully awake, 1, sleeping aroused by verbal stimuli, 2 sleeping, aroused by physical stimuli, 3 sleeping, cannot be aroused.
Oxygen saturation (%): 0 ≥ 94, 1 90-93, 2 85-89, 3 &lt;85. Blood pressure, systolic (mmHg): 0 100-220, 1 90-99. 2 80-89 or &gt;220, 3&lt;80. Heart rate; pr. min: 0 50-100, 1 101-120, 2 40-49 or 121-130, 3 &lt;40 or &gt;130. Pain (at rest) (Numeric rating scale 0-10): 0 0, 1 0-2, 2 3-6, 3 ≥ 7 Nausea (patient evaluation and nurse observation): 0 none, 1 light, 2 moderate, 3 severe or vomiting.</description>
        <time_frame>within 3 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Discharge Score, Arrival at PACU</title>
          <description>DASAIM score (Danish Society of Anesthesiology and Intensive Care Medicine). The score consists of six modalities: Sedation, Oxygen saturation, blood pressure, heart rate, pain (at rest) and nausea.
Each modality has a score between 0 and 3, and patients are considered dischargeable to the ward when the score sum of all criteria is four or less and no single score is above one.
Sedation: 0 fully awake, 1, sleeping aroused by verbal stimuli, 2 sleeping, aroused by physical stimuli, 3 sleeping, cannot be aroused.
Oxygen saturation (%): 0 ≥ 94, 1 90-93, 2 85-89, 3 &lt;85. Blood pressure, systolic (mmHg): 0 100-220, 1 90-99. 2 80-89 or &gt;220, 3&lt;80. Heart rate; pr. min: 0 50-100, 1 101-120, 2 40-49 or 121-130, 3 &lt;40 or &gt;130. Pain (at rest) (Numeric rating scale 0-10): 0 0, 1 0-2, 2 3-6, 3 ≥ 7 Nausea (patient evaluation and nurse observation): 0 none, 1 light, 2 moderate, 3 severe or vomiting.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.294</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Discharge Score, Arrival at Ward</title>
        <description>DASAIM score (Danish Society of Anesthesiology and Intensive Care Medicine). The score consists of six modalities: Sedation, Oxygen saturation, blood pressure, heart rate, pain (at rest) and nausea.
Each modality has a score between 0 and 3, and patients are considered dischargeable to the ward when the score sum of all criteria is four or less and no single score is above one.
Sedation: 0 fully awake, 1, sleeping aroused by verbal stimuli, 2 sleeping, aroused by physical stimuli, 3 sleeping, cannot be aroused.
Oxygen saturation (%): 0 ≥ 94, 1 90-93, 2 85-89, 3 &lt;85. Blood pressure, systolic (mmHg): 0 100-220, 1 90-99. 2 80-89 or &gt;220, 3&lt;80. Heart rate; pr. min: 0 50-100, 1 101-120, 2 40-49 or 121-130, 3 &lt;40 or &gt;130. Pain (at rest) (Numeric rating scale 0-10): 0 0, 1 0-2, 2 3-6, 3 ≥ 7 Nausea (patient evaluation and nurse observation): 0 none, 1 light, 2 moderate, 3 severe or vomiting.</description>
        <time_frame>within 3 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Discharge Score, Arrival at Ward</title>
          <description>DASAIM score (Danish Society of Anesthesiology and Intensive Care Medicine). The score consists of six modalities: Sedation, Oxygen saturation, blood pressure, heart rate, pain (at rest) and nausea.
Each modality has a score between 0 and 3, and patients are considered dischargeable to the ward when the score sum of all criteria is four or less and no single score is above one.
Sedation: 0 fully awake, 1, sleeping aroused by verbal stimuli, 2 sleeping, aroused by physical stimuli, 3 sleeping, cannot be aroused.
Oxygen saturation (%): 0 ≥ 94, 1 90-93, 2 85-89, 3 &lt;85. Blood pressure, systolic (mmHg): 0 100-220, 1 90-99. 2 80-89 or &gt;220, 3&lt;80. Heart rate; pr. min: 0 50-100, 1 101-120, 2 40-49 or 121-130, 3 &lt;40 or &gt;130. Pain (at rest) (Numeric rating scale 0-10): 0 0, 1 0-2, 2 3-6, 3 ≥ 7 Nausea (patient evaluation and nurse observation): 0 none, 1 light, 2 moderate, 3 severe or vomiting.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="1" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="1" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Complication</title>
        <description>complications requiring treatment until discharge</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Complication</title>
          <description>complications requiring treatment until discharge</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Length of Stay in PACU</title>
        <description>Length of stay in the post-anesthesia care unit (PACU), measured as hours and minutes, from start of procedure, to discharge from PACU</description>
        <time_frame>12 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Total Length of Stay in PACU</title>
          <description>Length of stay in the post-anesthesia care unit (PACU), measured as hours and minutes, from start of procedure, to discharge from PACU</description>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" lower_limit="1.4" upper_limit="2.4"/>
                    <measurement group_id="O2" value="1.5" lower_limit="1.4" upper_limit="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.350</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Length of Stay in Hospital</title>
        <description>Length of stay in hospital, measured from start of procedure to discharge from hospital to home</description>
        <time_frame>24-48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Total Length of Stay in Hospital</title>
          <description>Length of stay in hospital, measured from start of procedure to discharge from hospital to home</description>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" lower_limit="7.4" upper_limit="24.4"/>
                    <measurement group_id="O2" value="11" lower_limit="8.1" upper_limit="23.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.217</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Secondary Transfer</title>
        <description>Secondary transfer to PACU from ward, or to intensive care unit from PACU</description>
        <time_frame>24-48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Secondary Transfer</title>
          <description>Secondary transfer to PACU from ward, or to intensive care unit from PACU</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain, Numeric Rating Scale</title>
        <description>Self-reported pain (worst and average (average through that day), days 0-4) on a numeric rating scale (NRS) 0-10. 0 is no pain, 10 is worst pain imaginable.. Questionnaire.</description>
        <time_frame>days 0-4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Pain, Numeric Rating Scale</title>
          <description>Self-reported pain (worst and average (average through that day), days 0-4) on a numeric rating scale (NRS) 0-10. 0 is no pain, 10 is worst pain imaginable.. Questionnaire.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 0, average</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, average</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="1" lower_limit="1" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, average</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3, average</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4, average</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="2"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 0, worst</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="0" upper_limit="5.75"/>
                    <measurement group_id="O2" value="3" lower_limit="1" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 1, worst</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="1.5" lower_limit="1" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2, worst</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="2" lower_limit="0" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3, worst</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="1"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4, worst</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="O2" value="1" lower_limit="0" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.193</p_value>
            <p_value_desc>a priori threshold, bonferroni corrected 0.0125</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post Operative Nausea and Vomiting (PONV).</title>
        <description>Self-reported nausea, questionnaire, day 0-4. Number of participants reporting nausea and/or vomiting</description>
        <time_frame>days 0-4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Post Operative Nausea and Vomiting (PONV).</title>
          <description>Self-reported nausea, questionnaire, day 0-4. Number of participants reporting nausea and/or vomiting</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>DAY 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.2</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Sleep</title>
        <description>Self-reported quality of sleep (days 0-4). Questionnaire. Dichotomized to Good sleep or sleep problems, numbers reported are number of patients with sleep problems</description>
        <time_frame>days 0-4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Sleep</title>
          <description>Self-reported quality of sleep (days 0-4). Questionnaire. Dichotomized to Good sleep or sleep problems, numbers reported are number of patients with sleep problems</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>DAY 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.136</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mental Status</title>
        <description>Self-reported feelings of restlessness, sadness and fatigue (days 0-4). Questionnaire (anwers possible: yes or no. Numbers are patients answering yes)</description>
        <time_frame>days 0-4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Mental Status</title>
          <description>Self-reported feelings of restlessness, sadness and fatigue (days 0-4). Questionnaire (anwers possible: yes or no. Numbers are patients answering yes)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>DAY 0 : restlessness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 0 : sadness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 0 : fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 1 : restlessness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 1 : sadness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 1 : fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 2 : restlessness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 2 : sadness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 2 : fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 3 : restlessness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 3 : sadness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 3 : fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 4 : restlessness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 4 : sadness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DAY 4 : fatigue</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;0.003</p_value>
            <p_value_desc>A priori threshold for statistical significans was 0.00125 due to multiple comparisons</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Seroma, Requiring Treatment</title>
        <description>Seroma, requiring treatment the first 14 days.</description>
        <time_frame>14 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Seroma, Requiring Treatment</title>
          <description>Seroma, requiring treatment the first 14 days.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.030</p_value>
            <method>Chi-squared</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.53</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.07</ci_lower_limit>
            <ci_upper_limit>11.6</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Readmission</title>
        <description>Any readmission, days 0-30</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Dexamethasone 8 mg</title>
            <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
          <group group_id="O2">
            <title>Dexamethasone 24 mg</title>
            <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
          </group>
        </group_list>
        <measure>
          <title>Readmission</title>
          <description>Any readmission, days 0-30</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="63"/>
                <count group_id="O2" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>60 hours from administration of study drug</time_frame>
      <desc>Adverse events are collected from patients that received the study drug (63 and 64 in the 8 and 24 mg group respectively), we had 3 post-randomization exclusion, they did not receive the study drug and adverse events were not collected in agreement with the Good Clinical Practise (GCP) monitor</desc>
      <group_list>
        <group group_id="E1">
          <title>Dexamethasone 8 mg</title>
          <description>Dexamethasone 8 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
        </group>
        <group group_id="E2">
          <title>Dexamethasone 24 mg</title>
          <description>Dexamethasone 24 mg pre-operative
Dexamethasone: pre-operative intravenous administration</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="64"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>wound hemorrhage</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="63"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="63"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="64"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>kristin steinthorsdottir, md</name_or_title>
      <organization>rigshospitalet</organization>
      <phone>31666112</phone>
      <email>kjs@dadlnet.dk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

